<DOC>
	<DOCNO>NCT00629603</DOCNO>
	<brief_summary>Hepatitis C virus ( HCV ) infection cause different disease spectrum range minimal progressive liver disease cirrhosis hepatocellular carcinoma . Evidence indicate host genetic factor may play role determine disease progression . It know many cytokine polymorphism affect disease progressin via increase hepatic fibrosis key factor progress liver injury . By combination fibrosis-relating gene polymorphism , study aim identify patient high risk progressive liver disease . These patient need intensive therapy decrease morbidity mortality chronic HCV-related liver disease .</brief_summary>
	<brief_title>Polymorphisms Fibrosis-Relating Genes Outcome HCV-Related Chronic Liver Disease</brief_title>
	<detailed_description>Determination follow fibrosis-relating gene polymorphism HCV-related chronic liver disease HCC perform : TNF-α , TNF-β , Factor V Leiden , TGF-β1 , PDGF-B gene , Angiotensinogen ( AT ) , Angiotensin convert enzyme ( ACE ) , microsomal epoxide hydrolase ( mEH ) glutathione-S-transferase ( GST ) .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Patients antiHCV positive AntiHCVnegative patient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>hepatitis C virus infection</keyword>
	<keyword>chronic liver disease</keyword>
	<keyword>fibrosis-related cytokine</keyword>
</DOC>